RA CAPITAL MANAGEMENT, L.P. Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$969.4B
Holdings
30
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES PTE LTD | 7,088,651 | $230.2B | 23.74% | |
| 2 | —ACHILLION PHARMACEUTICALS INC | 12,033,220 | $97.5B | 10.05% | |
| 3 | ASNDASCENDIS PHARMA A S | 3,681,491 | $74.0B | 7.63% | |
| 4 | —AVEXIS INC | 1,732,274 | $71.4B | 7.36% | |
| 5 | —AXOVANT SCIENCES LTD | 5,000,000 | $70.0B | 7.22% | |
| 6 | NKTREURNEKTAR THERAPEUTICS | 3,664,154 | $63.0B | 6.49% | |
| 7 | ARDXARDELYX INC | 3,266,045 | $42.3B | 4.36% | |
| 8 | ACRSACLARIS THERAPEUTICS INC | 1,547,152 | $39.6B | 4.09% | |
| 9 | TGTXTG THERAPEUTICS INC | 4,631,114 | $35.8B | 3.70% | |
| 10 | —AQUINOX PHARMACEUTICALS INC | 2,191,977 | $29.3B | 3.02% | |
| 11 | —ZOGENIX INC | 2,451,237 | $28.0B | 2.89% | |
| 12 | —AIMMUNE THERAPEUTICS INC | 1,292,940 | $19.4B | 2.00% | |
| 13 | —FOAMIX PHARMACEUTICALS LTD | 1,820,138 | $16.9B | 1.74% | |
| 14 | PTGXPROTAGONIST THERAPEUTICS INC | 754,411 | $15.9B | 1.64% | |
| 15 | —PROTEON THERAPEUTICS INC | 1,626,931 | $15.2B | 1.57% | |
| 16 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $14.3B | 1.47% | |
| 17 | BCRXBIOCRYST PHARMACEUTICALS | 2,989,795 | $13.2B | 1.36% | |
| 18 | —STRONGBRIDGE BIOPHARMA PLC | 2,501,667 | $13.1B | 1.35% | |
| 19 | —AUDENTES THERAPEUTICS INC | 707,426 | $12.6B | 1.30% | |
| 20 | —DIMENSION THERAPEUTICS INC | 1,548,033 | $12.4B | 1.28% | |
| 21 | XLRNACCELERON PHARMA INC | 318,565 | $11.5B | 1.19% | |
| 22 | ARWRARROWHEAD PHARMACEUTICALS INC | 1,525,424 | $11.2B | 1.16% | |
| 23 | —TENAX THERAPEUTICS INC | 2,389,700 | $5.5B | 0.57% | |
| 24 | ONCBEIGENE LTD | 170,000 | $5.2B | 0.54% | |
| 25 | —ALCOBRA LTD | 2,044,756 | $5.1B | 0.52% | |
| 26 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 354,200 | $4.7B | 0.49% | |
| 27 | GBYSANGAMO BIOSCIENCES INC | 899,438 | $4.2B | 0.43% | |
| 28 | —MERUS N V | 204,929 | $3.4B | 0.35% | |
| 29 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 336,134 | $2.2B | 0.22% | |
| 30 | —ARCA BIOPHARMA INC | 521,606 | $1.5B | 0.15% | |
| 31 | —AKARI THERAPEUTICS PLC | 114,039 | $970.0M | 0.10% |